The dialysis machines sector in India makes up around 3% of the Asia Pacific market, with the majority of machines being imported, leading to increased expenses. GlobalData reported that the market is expected to reach $14 million by 2033 due to...
Continuous innovation and biopharmaceutical research are driving growth in the specialty pharmaceutical market. The industry's dedication to creating innovative treatment choices plays a crucial role in achieving better disease targeting with...
The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the...
Shanghai Pharmaceuticals is the biggest drug importer in China and the second largest distributor of pharmaceuticals. Shanghai Pharmaceuticals generates $37 billion in total revenue and produces medications for cancer, diabetes, cardiovascular...
India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030. CPHI & P-MEC India exemplifies this growth by connecting global and domestic stakeholders to showcase...
Aptar is assisting Indian pharmaceutical firms in the launch of inhalers and nasal sprays for both local and export markets. Aptar is the top global supplier of inhalation devices, essential for administering medications used to manage respiratory...
In 2023, international pharmaceutical firms supplied clinical trial medications to local patients valued at approximately 320.8 billion. The overall quantity of clinical trials carried out that year was 1,723, reflecting a 7.7 percent rise...
The US investments mark the initial phase of significant actions aimed at supporting AstraZeneca's goal of reaching $80 billion in overall revenue by 2030, as outlined in May of this year. An essential aspect of our approach is hastening the...
Among the leading 10 therapies that account for over 90% of the Indian pharmaceutical market, price was the key factor in the expansion of the cardiac sector. The anti-hypertensive medications, comprising nearly 50% of the cardiac sector, are...
India is presently the fourth largest medical device market in Asia, boasting an industry valued at USD 14 billion and exports totaling USD 3.7 billion. The MedTech program is expected to assist local manufacturers in expanding the market value to...
, CDSCO.jpg)
